Plus Therapeutics (PSTV)
(Real Time Quote from BATS)
$1.56 USD
-0.08 (-4.88%)
Updated Sep 23, 2024 01:18 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Plus Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -13.32 | -20.28 | -13.40 | -8.24 | -10.89 |
Depreciation/Amortization & Depletion | 0.82 | 1.01 | 0.94 | 0.95 | 1.45 |
Net Change from Assets/Liabilities | -1.12 | 5.60 | 1.24 | 0.12 | -0.94 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.76 | 0.70 | 0.94 | -1.26 | 4.47 |
Net Cash From Operating Activities | -12.85 | -12.97 | -10.28 | -8.43 | -5.91 |
Property & Equipment | -0.16 | -0.51 | -0.08 | -0.09 | -0.07 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 5.64 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | -0.25 | 0.00 | -0.40 | 0.00 |
Net Cash from Investing Activities | -0.16 | -0.76 | -0.08 | -0.49 | 5.57 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.40 | 15.06 | 20.69 | 5.11 | 16.45 |
Issuance (Repayment) of Debt | -1.61 | -1.61 | -0.28 | -5.42 | -3.82 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.35 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 3.45 | 13.45 | 20.42 | -0.32 | 12.63 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -9.57 | -0.28 | 10.05 | -9.25 | 12.29 |
Cash at Beginning of Period | 18.12 | 18.40 | 8.35 | 17.59 | 5.30 |
Cash at End of Period | 8.55 | 18.12 | 18.40 | 8.35 | 17.59 |
Diluted Net EPS | -4.24 | -11.54 | -16.64 | -27.89 | -123.99 |
Fiscal Year End for Plus Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -6.20 | -3.26 | -13.32 | -9.51 | -6.29 |
Depreciation/Amortization & Depletion | 0.35 | 0.17 | 0.82 | 0.64 | 0.44 |
Net Change from Assets/Liabilities | 1.01 | -1.60 | -1.12 | -2.69 | -3.06 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -0.81 | 0.18 | 0.76 | 0.59 | 0.34 |
Net Cash From Operating Activities | -5.66 | -4.51 | -12.85 | -10.97 | -8.57 |
Property & Equipment | -0.12 | -0.04 | -0.16 | -0.12 | -0.11 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -3.50 | -0.32 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.55 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -4.17 | -0.36 | -0.16 | -0.12 | -0.11 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.89 | -0.37 | 5.40 | 5.18 | 2.26 |
Issuance (Repayment) of Debt | -4.00 | -0.40 | -1.61 | -1.21 | -0.80 |
Increase (Decrease) Short-Term Debt | 3.29 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -0.35 | 0.00 | 0.00 |
Net Cash from Financing Activities | 6.19 | -0.78 | 3.45 | 3.97 | 1.45 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -3.64 | -5.65 | -9.57 | -7.11 | -7.23 |
Cash at Beginning of Period | 8.55 | 8.55 | 18.12 | 18.12 | 18.12 |
Cash at End of Period | 4.91 | 2.90 | 8.55 | 11.01 | 10.90 |
Diluted Net EPS | -0.71 | -0.75 | -0.55 | -1.00 | -0.59 |